Skip to main content Accessibility help
×
Home
Hostname: page-component-564cf476b6-dr4jh Total loading time: 0.379 Render date: 2021-06-18T16:14:51.541Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true }

Serratia Bacteremia in a Large University Hospital: Trends in Antibiotic Resistance During 10 Years and Implications for Antibiotic Use

Published online by Cambridge University Press:  02 January 2015

Sang-Ho Choi
Affiliation:
Division of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Yang Soo Kim
Affiliation:
Division of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Jin-Won Chung
Affiliation:
Division of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Tae Hyong Kim
Affiliation:
Division of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Eun Ju Choo
Affiliation:
Division of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Mi-Na Kim
Affiliation:
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Baek-Nam Kim
Affiliation:
Division of Infectious Diseases, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea
Nam Joong Kim
Affiliation:
Division of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Jun Hee Woo
Affiliation:
Division of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Jiso Ryu
Affiliation:
Division of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Abstract

Objective:

To identify antibiotic resistance trends and risk factors for resistance of Serratia species to third-generation cephalosporins.

Design:

Retrospective survey of medical records.

Setting:

A 2,200-bed, tertiary-care hospital.

Patients:

One hundred twenty-two patients with Serratia bacteremia between January 1991 and June 2001.

Methods:

Infectious disease physicians collected data from medical records regarding patient demographics, underlying disease or condition, portal of entry, microorganism, antibiogram, complications, antibiotics received, and outcome.

Results:

Among 122 Serratia isolates, 117 (95.9%) were Serratia marcescens and 110 (90.2%) were of nosocomial origin. During the study period, the 122 isolates showed a high rate of resistance to third-generation cephalosporins (45.9%) and extended-spectrum penicillins (56.6%). The resistance rate to ciprofloxacin was 32.0%. The resistance rate to third-generation cephalosporins increased from 31.7% for 1991 to 1995 to 54.9% for 1996 to 1998 and 50.0% for 1999 to 2001. In the multivariate analysis, prior use of a second-generation cephalosporin (adjusted odds ratio [OR], 5.90; 95% confidence interval [CI95], 1.41 to 24.6; P = .015) or a third-generation cephalosporin (OR, 3.26; CI95, 1.20 to 8.87; P = .020) was a strong independent risk factor for resistance to third-generation cephalosporins. The overall case-fatality rate was 25.4% (Serratia bacteremia-related case-fatality rate, 13.1%).

Conclusion:

Prior use of a second- or third-generation cephalosporin was the most important risk factor for bacteremia with Serratia resistant to third-generation cephalosporins, suggesting the need for antibiotic control. The potential role of patient-to-patient spread could not be fully evaluated in this retrospective study.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2002

Access options

Get access to the full version of this content by using one of the access options below.

References

1.Gatell, JM, Trilla, A, Latorre, X, et al. Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. Rev Infect Dis 1988;10:203210.CrossRefGoogle Scholar
2.Pfaller, MA, Jones, RN, Marshall, SAet al. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis 1997;28:211219.CrossRefGoogle Scholar
3.Edmond, MB, Wallace, SE, McClish, DK, Pfaller, MA, Jones, RN, Wenzel, RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29:239244.CrossRefGoogle ScholarPubMed
4.Richards, NM, Levitsky, S. Outbreaks of Serratia marcescens infections in a cardiothoracic surgical intensive care unit. Ann Thorac Surg 1975;19:503513.CrossRefGoogle Scholar
5.Geiseler, PJ, Harris, B, Andersen, BR. Nosocomial outbreak of nitrate-negative Serratia marcescens infections. J Clin Microbiol 1982;15:728730.Google Scholar
6.Duggan, TG, Leng, RA, Hancock, BM, Cursons, RT. Serratia marcescens in a newborn unit: microbiological features. Pathology 1984;16:189191.CrossRefGoogle Scholar
7.Fry, DE, Fry, RV, Shlaes, DM. Serratial bacteremia in the surgical patient. Am Surg 1987;53:438441.Google ScholarPubMed
8.Villarino, ME, Jarvis, WR, O'Hara, C, Bresnahan, J, Clark, N. Epidemic of Serratia marcescens bacteremia in a cardiac intensive care unit. J Clin Microbiol 1989;27:24332436.Google Scholar
9.Sokalski, SJ, Jewell, MA, Asmus-Shillington, , , AC, Mulcahy, J, Segreti, J. An outbreak of Serratia marcescens in 14 adult cardiac surgical patients associated with 12-lead electrocardiogram bulbs. Arch Intern Med 1992;152:841844.CrossRefGoogle ScholarPubMed
10.van Ogtrop, ML, van Zoeren-Grobben, D, Verbakel-Salomons, EM, van Boven, CP. Serratia marcescens infections in neonatal departments: description of an outbreak and review of the literature. J Hosp Infect 1997;36:95103.CrossRefGoogle ScholarPubMed
11.Harnett, SJ, Allen, KD, Macmillan, RR. Critical care unit outbreak of Serratia liquefaciens from contaminated pressure monitoring equipment. J Hosp Infect 2001;47:301307.CrossRefGoogle ScholarPubMed
12.Grohskopf, LA, Roth, VR, Feikin, DRet al. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med 2001;344:14911497.CrossRefGoogle Scholar
13.Yu, VL. Serratia marcescens: historical perspective and clinical review. N Engl J Med 1979;300:887893.CrossRefGoogle ScholarPubMed
14.Eisenstein, BI, Zaleznik, DE. Enterobacteriaceae. In: Mandell, GL, Douglas, RG, Bennett, JE, Dolin, R, eds. Principles and Practice of Infectious Diseases, 5th ed. Philadelphia: Churchill Livingstone; 2000:22972310.Google Scholar
15.Livermore, DM. Clinical significance of β-lactamase induction and stable derepression in gram-negative rods. Eur J Clin Microbiol 1987;6:439445.CrossRefGoogle Scholar
16.Sanders, CC, Sanders, WE Jr. β-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992;15:824839.CrossRefGoogle Scholar
17.Bennett, PM, Chopra, I. Molecular basis of β-lactamase induction in bacteria. Antimicrob Agents Chemother 1993;37:153158.CrossRefGoogle ScholarPubMed
18.Dworzack, DL, Pugsley, MP, Sanders, CC, Horowitz, EA. Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins. Eur J Clin Microbiol 1987;6:456459.CrossRefGoogle ScholarPubMed
19.Dodson, WH. Serratia marcescens septicemia. Arch Intern Med 1968,121: 145150.CrossRefGoogle ScholarPubMed
20.Wilfert, JN, Barrett, FF, Kass, EH. Bacteremia due to Serratia marcescens. N Engl J Med 1968;279:286289.CrossRefGoogle ScholarPubMed
21.Henjyoji, EY, Whitson, TC, Ohashi, DK, Allen, BD. Bacteremia due to Serratia marcescens. J Trauma 1971;11:417421.CrossRefGoogle ScholarPubMed
22.Crowder, JG, Gilkey, GH, White, AC. Serratia marcescens bacteremia: clinical observations and studies of precipitin reactions. Arch Intern Med 1971;128:247253.CrossRefGoogle ScholarPubMed
23.Bouza, E, Garcia de la Torre, M, Erice, A, Cercenado, E, Loza, E, Rodriguez-Creixems, M. Serratia bacteremia. Diagn Microbiol Infect Dis 1987;7:237247.CrossRefGoogle ScholarPubMed
24.Sanchez Ruano, JJ, Garcia Díaz, JD, Alonso Navas, F. Serratia marcescens bacteremia: a report of 83 cases [in Spanish]. Medica Clinica 1988; 90:479483.Google Scholar
25.Saito, H, Elting, L, Bodey, GP, Berkey, R. Serratia bacteremia: review of 118 cases. Rev Infect Dis 1989;11:912920.CrossRefGoogle Scholar
26.Watanakunakorn, C. Serratia bacteremia: a review of 44 episodes. Scand J Infect Dis 1989;21:477483.CrossRefGoogle ScholarPubMed
27.Wong, WW, Wang, LS, Cheng, DL, et al. Serratia marcescens bacteremia. J Formos Med Assoc 1991;90:8893.Google ScholarPubMed
28.Haddy, RI, Mann, BL, Nadkarni, DD, et al. Nosocomial infection in the community hospital: severe infection due to Serratia species. J Fam Pract 1996;42:273277.Google ScholarPubMed
29.Yu, WL, Lin, CW, Wang, DY. Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of the isolates. J Microbiol Immunol Infect 1998;31:171179.Google ScholarPubMed
30.McCabe, WR, Jackson, GG. Gram-negative bacteremia: II. Clinical, laboratory, and therapeutic observations. Arch Intern Med 1962;110:856864.CrossRefGoogle Scholar
31.Chow, JW, Fine, MJ, Shlaes, DM, et al. Enterobacterbacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585590.CrossRefGoogle Scholar
32.National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Ninth Informational Supplement M100-S9. Wayne, PA: National Committee for Clinical Laboratory Standards; 1999.Google Scholar
33.Jones, RN. Important and emerging β-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes. Diagn Microbiol Infect Dis 1998;31:461466.CrossRefGoogle Scholar
34.D'Agata, E, Venkataraman, L, DeGirolami, R, Weigel, L, Samore, M, Tenover, E. The molecular and clinical epidemiology of Enterobacteriaceae-producing extended-spectrum beta-lactamase in a tertiary care hospital. J Infect 1998;36:279285.CrossRefGoogle Scholar
35.De Champs, C, Rouby, D, Guelon, D, et al. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase.J Hosp Infect 1991;18:513.CrossRefGoogle ScholarPubMed
36.Jacoby, GA. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactamse. Incet Dis Clin North Am 1997;11:875887.CrossRefGoogle Scholar
37.Kaye, KS, Fraimow, HS, Abrutyn, E. Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am 2000;14:293319.CrossRefGoogle ScholarPubMed
38.Meyer, KS, Urban, C, Eagan, JA, Berger, BJ, Rahal, JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353358.CrossRefGoogle Scholar
39.Pena, C, Pujol, M, Ardanuy, C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1998;42:5358.Google Scholar
40.Schiappa, DA, Hayden, MK, Matushek, MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996;174: 529536.CrossRefGoogle ScholarPubMed
41.Wiener, J, Quinn, JP, Bradford, PAet al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999;281:517523.CrossRefGoogle ScholarPubMed
42.Livermore, DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557584.Google ScholarPubMed
43.Pitout, JD, Sanders, CC, Sanders, WE Jr. Antimicrobial resistance with focus on β-lactam resistance in gram-negative bacilli. Am J Med 1997; 103:5159.CrossRefGoogle ScholarPubMed
44.Jacobson, KL, Cohen, SH, Inciardi, JF, et al. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I β-lactamase-producing organisms. Clin Infect Dis 1995;21:11071113.CrossRefGoogle ScholarPubMed
45.Sahm, DF, Storch, G. Amp C β-lactamases. Pediatr Infect Dis J 1998; 17:421422.CrossRefGoogle Scholar
46.Sanders, WE Jr, Sanders, CC. Inducible β-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. Rev Infect Dis 1988;10:830838.CrossRefGoogle ScholarPubMed
47.Livermore, DM. Carbapenemases. J Antimicrob Chemother 1992;29:609613.CrossRefGoogle ScholarPubMed
48.Naas, T, Vandel, L, Sougakoff, W, Livermore, DM, Nordmann, P. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A β-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob Agents Chemother 1994;38:12621270.CrossRefGoogle Scholar
49.Palomar, J, Puig, M, Montilla, R, Loren, JG, Vinas, M. Lipopolysaccharide recovery restores susceptibility levels towards β-lactamase in Serratia marcescens. Microbios 1995;82:2126.Google Scholar
50.Cunha, BA. Antibiotic resistance. Med Clin North Am 2000;84:14071429.CrossRefGoogle ScholarPubMed
51.Friedrich, LV, White, RL, Bosso, JA. Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes. Clin Infed Dis 1999;28:10171024.CrossRefGoogle Scholar
52.Kaye, KS, Cosgrove, S, Harris, A, Eliopoulos, GM, Carmeli, Y. Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobader spp. Antimicrob Agents Chemother 2001;45:26282630.CrossRefGoogle ScholarPubMed
26
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Serratia Bacteremia in a Large University Hospital: Trends in Antibiotic Resistance During 10 Years and Implications for Antibiotic Use
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Serratia Bacteremia in a Large University Hospital: Trends in Antibiotic Resistance During 10 Years and Implications for Antibiotic Use
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Serratia Bacteremia in a Large University Hospital: Trends in Antibiotic Resistance During 10 Years and Implications for Antibiotic Use
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *